MEDB-37. Chemotherapy response prediction by molecular risk factors in metastatic childhood medulloblastoma

BACKGROUND: Childhood metastatic medulloblastoma (MB) frequently receive postoperative chemotherapy (CT) before craniospinal irradiation. Some MB show stable (SD) or progressive disease (PD) upon CT. Identification of biomarkers for non-response might allow therapy-modifications. METHODS: Patients r...

Descripción completa

Detalles Bibliográficos
Autores principales: Obrecht, Denise, Bockmayr, Michael Ludwig, Bison, Brigitte, Pfister, Stefan M, Sturm, Dominik, Sahm, Felix, Jones, David T W, Sill, Martin, von Hoff, Katja, Benesch, Martin, Gerber, Nicolas U, von Bueren, André, Friedrich, Carsten, Pietsch, Torsten, Schüller, Ulrich, Mynarek, Martin, Rutkowski, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Medulloblastoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165010/
http://dx.doi.org/10.1093/neuonc/noac079.411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165010/
http://dx.doi.org/10.1093/neuonc/noac079.411

Ejemplares similares